Sarepta Therapeutics的动态

How might wearables change the future of clinical trials? Ask Landry, a playful 10-year-old from Iowa and a clinical trial pioneer. Landry lives with #Duchenne muscular dystrophy and recently participated in a Sarepta clinical trial that included a wearable device measuring stride speed. Incorporating novel endpoints, such as data from a wearable device, into clinical trials allows Sarepta to see the whole patient and evaluate how therapies may impact a person beyond the clinic appointment and in their everyday life. Visit our Newsroom to read more about Landry’s story and the potential for wearables in Duchenne drug developments: https://bit.ly/40Vi2tA #raredisease #clinicaltrials #wearables?

Paul Strijbos

Senior Principal Neurotech Innovation Leader at Roche

1 周

Great to see the joint Sarepta Therapeutics Roche effort on the use of the Syde wearable device and EMA Qualified endpoint SV95C in the pivotal ELEVIDYS program highlighted. Stefanie Mason

要查看或添加评论,请登录